A Quality-by-Design Approach to Optimize In-Process Curing of EUDRAGIT NM 30 D

According to the White House, the order builds on actions taken in the president’s first term to reduce price disparities domestically.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with the current standard of care, according to a phase III trial.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

FDA chooses Dr. Vinay Prasad, MD, MPH, a hematologist-oncologist, to lead the Center for Biologics Evaluation and Research at FDA.

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.